Stifel Nicolaus Upgrades Biogen (BIIB) to Hold
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $209.83 -0.39%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
An analyst at Stifel Nicolaus upgraded shares Biogen (NASDAQ: BIIB) from Sell to Hold Wednesday afternoon.
The stock is up 2 percent to $79.79 at last check.
Notably, Biogen shares were upgraded to Buy at BofA Merrill Lynch Tuesday.
For more ratings news on Biogen click here and for the rating history of Biogen click here.
The stock is up 2 percent to $79.79 at last check.
Notably, Biogen shares were upgraded to Buy at BofA Merrill Lynch Tuesday.
For more ratings news on Biogen click here and for the rating history of Biogen click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Biogen (BIIB) to Outperform
- Kepler Cheuvreux Upgrades Komax Holding AG (KOMN:SW) to Buy
- Jefferies Upgrades Minerva Neurosciences (NERV) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
